Document is current
Any future updates will be listed below
-
Authors
Pitcher, Louise E.
Mukherjee, Bipasha
Saathoff, Ashley M.
Eduvas, Zachary A.
Bartz, Josh
Zhang, Xu
Giorgadze, Nino
Pirtskhalava, Tamar
Habib, Amyn A.
LeBrasseur, Nathan K.
Tchkonia, Tamara
Kirkland, James L.
Dong, Xiao
Burma, Sandeep
Robbins, Paul D.
-
Funding
Funding for this research was provided by:
National Institutes of Health (T32AG029796, P01 AG062413, R01 CA246807, P01 AG062413)
National Aeronautics and Space Administration (80NSSC20K0732)
- License Information
-
More Information
Article History
Received: 5 June 2025
Accepted: 4 September 2025
First Online: 27 November 2025
Competing interests
: T.T. and J.L.K. have a financial interest related to this research, including patents and pending patents covering senolytic drugs and their uses held by Mayo Clinic. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and was conducted in compliance with Mayo Clinic and Cedars-Sinai conflict of interest policies. P.R. is a co-founder of Itasca Therapeutics and has filed multiple patents on senotherapeutics held by the University of Minnesota.
